HB‐EGF‐loaded nanovesicles enhance trophectodermal spheroid attachment and invasion
PROTEOMICS · 2024
DOI: 10.1002/pmic.202200145 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, 2024. Verfasst von Qi Hui Poh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Proteomics, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Heparin-binding EGF-like Growth Factor, Extracellular Vesicles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
The ability of trophectodermal cells (outer layer of the embryo) to attach to the endometrial cells and subsequently invade the underlying matrix are critical stages of embryo implantation during successful pregnancy establishment. Extracellular vesicles (EVs) have been implicated in embryo‐maternal crosstalk, capable of reprogramming endometrial cells towards a pro‐implantation signature and phenotype. However, challenges associated with EV yield and direct loading of biomolecules limit their therapeutic potential. We have previously established generation of cell‐derived nanovesicles (NVs) from human trophectodermal cells (hTSCs) and their capacity to reprogram endometrial cells to enhance adhesion and blastocyst outgrowth. Here, we employed a rapid NV loading strategy to encapsulate potent implantation molecules such as HB‐EGF (NV HBEGF ). We show these loaded NVs elicit EGFR‐mediated effects in recipient endometrial cells, activating kinase phosphorylation sites that modulate their activity (AKT S124/129, MAPK1 T185/Y187), and downstream signalling pathways and processes (AKT signal transduction, GTPase activity). Importantly, they enhanced target cell attachment and invasion. The phosphoproteomics and proteomics approach highlight NV HBEGF ‐mediated short‐term signalling patterns and long‐term reprogramming capabilities on endometrial cells which functionally enhance trophectodermal‐endometrial interactions. This proof‐of‐concept study demonstrates feasibility in enhancing the functional potency of NVs in the context of embryo implantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Proteomics, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
- Department of Biochemistry and Chemistry, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, Victoria, Australia.
- Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Victoria, Australia.
- Central Clinical School, Monash University, Melbourne, Victoria, Australia.
- Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia.
ORCID-Profile: Qi Hui Poh, Alin Rai, David W Greening
Förderung
- National Health and Medical Research Council
Zitieren
APA
Poh, Q. H., Rai, A., Cross, J., & Greening, D. W. (2024). HB‐EGF‐loaded nanovesicles enhance trophectodermal spheroid attachment and invasion. PROTEOMICS. https://doi.org/10.1002/pmic.202200145
Vancouver
Poh QH, Rai A, Cross J, Greening DW. HB‐EGF‐loaded nanovesicles enhance trophectodermal spheroid attachment and invasion. PROTEOMICS. 2024. doi:10.1002/pmic.202200145
BibTeX
@article{Poh2024,
author = {Poh, Qi Hui and Rai, Alin and Cross, Jonathon and Greening, David W},
title = {HB‐EGF‐loaded nanovesicles enhance trophectodermal spheroid attachment and invasion},
journal = {PROTEOMICS},
year = {2024},
doi = {10.1002/pmic.202200145}
}
EUVIMED